Medicare Enrolled

Dr. Thomas Bossi, DO

Family Medicine · Davison, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
8020 DAVISON RD, Davison, MI 48423
8106534145
In practice since 2006 (19 years)
NPI: 1346342235 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bossi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bossi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bossi

Dr. Thomas Bossi is a family medicine specialist in Davison, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bossi performed 711 Medicare services across 473 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bossi received a total of $8,915 from 53 pharmaceutical and/or device companies across 540 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bossi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 24% volume in MI $8,915 industry payments

Medicare Practice Summary

Medicare Utilization ↗
711
Medicare services
Top 24% in MI for family medicine
473
Unique beneficiaries
$50
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~37 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
292 $43 $134
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
117 $52 $197
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
78 $61 $229
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
75 $61 $157
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
63 $24 $266
Hospital discharge management, 30+ min
This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge.
23 $88 $282
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
23 $29 $40
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
21 $72 $83
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
19 $100 $269
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,915
Total received (2018-2024)
Avg $1,274/year across 7 years
Top 4% in MI for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
540
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,760 (98.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$155 (1.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,586
2023
$1,349
2022
$1,557
2021
$1,416
2020
$1,028
2019
$854
2018
$1,125

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$264
GlaxoSmithKline, LLC.
$258
Astellas Pharma US Inc
$155
Lilly USA, LLC
$151
Exact Sciences Corporation
$88
Novo Nordisk Inc
$79
Amgen Inc.
$56
Boehringer Ingelheim Pharmaceuticals, Inc.
$52
AstraZeneca Pharmaceuticals LP
$46
PFIZER INC.
$45
Sumitomo Pharma America, Inc.
$43
Bayer Healthcare Pharmaceuticals Inc.
$42
Indivior Inc.
$41
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$34
Dexcom, Inc.
$34
Paratek Pharmaceuticals, Inc.
$33
Merck Sharp & Dohme LLC
$32
E.R. Squibb & Sons, L.L.C.
$29
Kowa Pharmaceuticals America, Inc.
$28
Bioventus LLC
$23
UCB, Inc.
$21
Abbott Laboratories
$19
Takeda Pharmaceuticals U.S.A., Inc.
$14
Top 3 companies account for 42.7% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,364
AbbVie Inc.
$793
Novo Nordisk Inc
$658
PFIZER INC.
$502
ABBVIE INC.
$477
Lilly USA, LLC
$448
Amgen Inc.
$420
Amarin Pharma Inc.
$370
Biohaven Pharmaceuticals, Inc.
$321
Astellas Pharma US Inc
$282
Janssen Pharmaceuticals, Inc
$270
Teva Pharmaceuticals USA, Inc.
$220
Exact Sciences Corporation
$203
Novartis Pharmaceuticals Corporation
$186
Allergan, Inc.
$172
E.R. Squibb & Sons, L.L.C.
$163
AstraZeneca Pharmaceuticals LP
$157
Bioventus LLC
$145
Horizon Therapeutics plc
$143
UROVANT SCIENCES INC
$125
Boehringer Ingelheim Pharmaceuticals, Inc.
$117
Bayer HealthCare Pharmaceuticals Inc.
$98
Biohaven Pharmaceutical Holding Company Ltd.
$91
AbbVie, Inc.
$86
SANOFI PASTEUR INC.
$85
Abbott Laboratories
$80
Merck Sharp & Dohme Corporation
$69
Bayer Healthcare Pharmaceuticals Inc.
$65
Radius Health, Inc.
$62
Flexion Therapeutics, Inc.
$54
Sunovion Pharmaceuticals Inc.
$53
Dexcom, Inc.
$52
Sumitomo Pharma America, Inc.
$43
Indivior Inc.
$41
Otsuka America Pharmaceutical, Inc.
$41
Kowa Pharmaceuticals America, Inc.
$40
Mylan Specialty L.P.
$39
ABIOMED
$37
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$34
Takeda Pharmaceuticals U.S.A., Inc.
$34
Sanofi Pasteur Inc.
$33
Paratek Pharmaceuticals, Inc.
$33
Merck Sharp & Dohme LLC
$32
ITI, Inc.
$24
UCB, Inc.
$21
MAYNE PHARMA COMMERCIAL LLC
$20
Jazz Pharmaceuticals Inc.
$19
SANOFI-AVENTIS U.S. LLC
$19
JAZZ PHARMACEUTICALS INC.
$18
IBSA Pharma Inc.
$14
Shire North American Group Inc
$13
Krystal Biotech Inc
$13
Alnylam Pharmaceuticals Inc.
$13
Top 3 companies account for 31.6% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ADVAIR · AIMOVIG · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · APTIOM · AREXVY · Aimovig · AirDuo Digihaler · BEXSERO · BREO · BREZTRI · CAPLYTA · CHANTIX · COMIRNATY · Cologuard Collection Kit · DEXCOM G6 CGM SYSTEM · DUROLANE · Dexcom G6 Transmitter · Durolane · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · FARXIGA · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GARDASIL · GELSYN 3 · GELSYN-3 · GEMTESA · Humira · Impella · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · LEQVIO · LYRICA · MENACTRA · MENQUADFI · MOUNJARO · MYRBETRIQ · Myrbetriq · NUCALA · NURTEC ODT · NUZYRA · Nayzilam · OFEV · ONPATTRO · Otezla · Ozempic · PNEUMOVAX 23 · PREMARIN · PREVNAR 20 · Prolia · QULIPTA · QVAR · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SPIRIVA RESPIMAT · SUBLOCADE · SUNOSI · SYMBICORT · Saxenda · Seglentis · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tirosint · Tresiba · Tymlos · UBRELVY · VESICARE · VRAYLAR · VYJUVEK · VYVANSE · Vascepa · Veozah · Victoza · Wegovy · XARELTO · Yupelri · ZORYVE · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for family medicine in MI.

Looking for a family medicine specialist in Davison?
Compare family medicine physicians in the Davison area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
380
Per 100K population
94.0
County median income
$60,673
Nearest hospital
MCLAREN LAPEER REGION
8.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Bossi is a clinical cardiology specialist, with above-average Medicare volume (top 24% in MI), with low-engagement industry engagement in the top 4% of MI peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Bossi experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Bossi performed 292 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bossi receive payments from pharmaceutical companies?
Yes. Dr. Bossi received a total of $8,915 from 53 companies across 540 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bossi's costs compare to other family medicine physicians in Davison?
Dr. Bossi's average Medicare payment per service is $50. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bossi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →